Association between the Life's Essential 8 Health Behaviors and Prognosis in Patients with Advanced Cardiovascular-Kidney-Metabolic Syndrome.

Eur J Prev Cardiol

Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, No.139, Renmin Middle Road, Changsha, Hunan 410011, China.

Published: July 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: This study aimed to evaluate the association between the Life's Essential 8 (LE8) and mortality risk in patients with advanced cardiovascular-kidney-metabolic (CKM) syndrome, focusing on the prognostic impact of its health behavior and health factor components.

Method: A total of 10,321 participants were included from the NHANES. Kaplan-Meier curve and Cox proportional-hazards models, and restricted cubic splines (RCS) were used to assess the associations of LE8, health behaviors, and health factors with mortality risk.

Result: Among all participants, 2629 had advanced CKM syndrome. Over a median 78-month follow-up, 579 deaths occurred. Each 10-point increase in the LE8 score reduced advanced CKM syndrome risk by 15% (OR = 0.85), while low CVH increased risk by 105% (OR = 2.05). Advanced CKM syndrome was associated with higher mortality risks, while each 10-point increase in the LE8 score reduced mortality risk. However, no significant difference in mortality risk was observed between the moderate and high CVH groups. Notably, each 10-point increase in the health behavior score lowered all-cause (HR = 0.80), cardiovascular (HR = 0.83), and CKM-related mortality risk (HR = 0.82), while patients with moderate (HR = 2.08, 1.88, 1.94) and low CVH (HR = 3.25, 253, 2.89) faced higher mortality risks. In contrast, the health factor showed no significant association with mortality risk.

Conclusion: The LE8, particularly its health behavior, is independently associated with mortality in advanced CKM syndrome. These findings suggest that LE8-based behavioral interventions could potentially reduce risk in advanced CKM syndrome patients.

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurjpc/zwaf443DOI Listing

Publication Analysis

Top Keywords

ckm syndrome
24
advanced ckm
20
mortality risk
16
health behavior
12
10-point increase
12
mortality
9
association life's
8
life's essential
8
health
8
health behaviors
8

Similar Publications

The relationship between gut microbiota, diet, and cardiovascular-kidney-metabolic (CKM) health has attracted attention. However, the relationship between the dietary index for gut microbiota (DI-GM) and CKM syndrome has not yet been studied. Patients diagnosed with CKM syndrome from the NHANES 2007-2018 data were included.

View Article and Find Full Text PDF

Heterozygous Med13l mice recapitulate a developmental growth delay and craniofacial anomalies seen in MED13L syndrome.

Dev Dyn

September 2025

Department of Internal Medicine, Division of Cardiovascular Medicine, Francois M. Abboud Cardiovascular Research Center, Fraternal Order of Eagles Diabetes Research Center, University of Iowa, Iowa City, Iowa, USA.

Background: Gene transcription is crucial for embryo and postnatal development and is regulated by the Mediator complex. Mediator is comprised of four submodules, including the kinase submodule (CKM). The CKM consists of MED13, MED12, CDK8, and CCNC.

View Article and Find Full Text PDF

Background: The association of the triglyceride glucose (TyG) index and related TyG metrics with obesity indices has been demonstrated to correlate with the incidence of cardiovascular disease (CVD). Nonetheless, this relationship has not been thoroughly investigated in patients with cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3.

Methods: This study involved 7364 participants from the China Health and Retirement Longitudinal Study (CHARLS).

View Article and Find Full Text PDF

Established and Emerging Therapies for Cardiovascular-Kidney-Metabolic Syndrome: Harnessing the Benefits of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and Beyond.

Heart Lung Circ

September 2025

Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia; Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; Department of Cardiology, Central Adelaide Local Health Network, Adelaide, SA,

Cardiovascular-kidney-metabolic (CKM) syndrome is a term that is increasingly used to describe interconnected conditions that lead to poor health outcomes, including cardiovascular disease, chronic kidney disease, type 2 diabetes, and obesity. Historically, there have been very few targeted pharmacotherapies available that have changed cardiovascular outcomes for people with CKM syndromes; however, over the past decade, new pharmacologic options have rapidly expanded, with strong evidence for cardiovascular and kidney protective benefits in CKM conditions. Of note, sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists have emerged as key therapeutic options and are now widely guideline-endorsed.

View Article and Find Full Text PDF

The Impact of Cardiovascular-Kidney-Metabolic Syndrome Staging on Depression Risk: A National Study.

Heart Lung Circ

September 2025

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

Background: Cardiovascular-kidney-metabolic (CKM) syndrome, recently defined by the American Heart Association, encompasses cardiovascular disease, chronic kidney disease, and metabolic disorders. However, its association with depression across different stages remains unclear.

Method: We analysed 4,097 adults from National Health and Nutrition Examination Survey 2005-2020.

View Article and Find Full Text PDF